Qualigen Therapeutics Q2 EPS $(0.69) Up From $(1.10) YoY, Sales $1.63M Up From $1.43M YoY
Qualigen Therapeutics Q2 EPS $(0.69) Up From $(1.10) YoY, Sales $1.63M Up From $1.43M YoY
Qualigen Therapeutics第二季度每股收益为0.69美元，高于同比1.10美元，销售额为163万美元，高于同比的143万美元
Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.69) per share. This is a 37.27 percent increase over losses of $(1.10) per share from the same period last year. The company reported $1.63 million in sales this quarter. This is a 13.70 percent increase over sales of $1.43 million the same period last year.
Qualigen Therapeutics（纳斯达克股票代码：QLGN）公布的季度亏损为每股0.69美元（0.69美元）。这比去年同期每股亏损1.10美元（1.10美元）增长了37.27％。该公司报告本季度销售额为163万美元。这比去年同期的143万美元销售额增长了13.70％。